As the European Union moves toward implementing new regulations for products developed through new genomic techniques, speakers at the 2026 International Non GMO Summit emphasized the growing demands to preserve transparency and traceability within non GMO value chains.

One of the central messages was that advances in genome editing technologies do not eliminate the need for science based risk assessment. Dr. Margret Engelhard of Germany’s Federal Agency for Nature Conservation argued that increasingly sophisticated genome editing techniques have expanded scientists’ ability to modify plant genomes faster than researchers can fully understand their biological and ecological effects. She maintained that similarity to conventionally bred crops should not automatically be treated as evidence of safety and supported continued case by case regulatory review.

A second topic centered on verification. Researchers participating in the European Union funded DARWIN project presented progress toward identifying genome edited crops using distinctive genetic fingerprints. Rather than relying on the detection of inserted foreign DNA, scientists are developing analytical methods capable of identifying specific single nucleotide variations associated with individual genome edited varieties. Summit participants suggested these approaches could help maintain non GMO verification programs if genome edited crops become more widely commercialized.

Consumer expectations also remained a prominent theme. Survey results presented by Prof. Dr. Holger Buxel of FH Münster University of Applied Sciences found that many German consumers remain unaware that future EU legislation could exempt certain genome edited crops from mandatory GMO labeling. Once informed, however, most respondents favored maintaining transparency, with a majority indicating that foods produced without new genomic techniques remain important purchasing considerations.